A prospective study to compare the efficacy of ICG dye Angiography and Parathyroid Hormone measurement in earlyprediction of risk of decrease in blood calcium levels after thyroid surgery.
- Conditions
- Health Condition 1: C73- Malignant neoplasm of thyroid glandHealth Condition 2: E040- Nontoxic diffuse goiterHealth Condition 3: E049- Nontoxic goiter, unspecifiedHealth Condition 4: E049- Nontoxic goiter, unspecifiedHealth Condition 5: E042- Nontoxic multinodular goiterHealth Condition 6: E041- Nontoxic single thyroid noduleHealth Condition 7: E048- Other specified nontoxic goiter
- Registration Number
- CTRI/2022/04/042270
- Lead Sponsor
- Department of Endocrine Surgery SGPGIMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
1. Patients who are going to undergo total
thyroidectomy, with or without cervical lymph node dissection for both benign and malignant conditions.
2. Normal renal
and hepatic functions.
3. Absence of a history of hypersensitivity reactions to iodine or indocyanine green.
4. Able to
understand the nature and protocol of the study and its procedures.
5.Willingness to participate with the subsequent
signing of informed consent
1. Age <18 years 2. Hepatic or renal insufficiency 3. Hypersensitivity
to iodine or to indocyanine green. 4. Pregnancy or lactation 5.Inability to understand the nature and procedures of the
study. 6. Previous thyroid and parathyroid surgery. 7. Patients with known preoperative hyperparathyroidism or any
concomitant parathyroid disease. 8. Previous treatment with calcium.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method